The Relationship between Serum Vitamin C and Uric Acid Levels, Antioxidant Status and Coronary Artery Disease: a

Aida Torkzaban1, Amirmansour Alavi Naeini1, Akbar Hassanzadeh2

  • 1Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.

Clinical Nutrition Research
|November 18, 2020
PubMed

Insights

Elevated uric acid and reduced vitamin C levels are linked to coronary artery disease (CAD). This study found these markers, but not overall antioxidant capacity, differed significantly between CAD patients and healthy individuals.

Area of Science:

  • Cardiology
  • Biochemistry
  • Nutritional Science

Background:

  • Coronary artery disease (CAD) is a leading cause of adult mortality.
  • Oxidative stress and impaired antioxidant defense contribute to atherosclerosis progression.
  • Understanding the role of specific antioxidants like uric acid and vitamin C in CAD is crucial.

Purpose of the Study:

  • To compare serum levels of uric acid (UA) and vitamin C in CAD patients versus healthy controls.
  • To assess and compare the total antioxidant capacity (TAC) and malondialdehyde (MDA) levels.
  • To investigate the association between these markers and CAD risk.

Main Methods:

  • A case-control study involving 44 CAD patients and 44 healthy controls.
  • Collection of demographic, anthropometric, dietary (FFQ), and physical activity (IPAQ) data.
  • Measurement of serum UA, vitamin C, TAC, and MDA levels after overnight fasting.

Main Results:

  • CAD patients showed significantly higher serum uric acid and lower serum vitamin C levels compared to controls.
  • No significant differences were found in serum MDA or TAC levels between the groups.
  • Dietary intake of certain vitamins and minerals did not significantly differ, except for vitamin C intake.

Conclusions:

  • Increased serum uric acid and decreased serum vitamin C may be risk factors for coronary artery disease.
  • The study suggests a potential role for UA and vitamin C in CAD pathogenesis.
  • Further research with larger sample sizes is required to clarify the relationship between TAC and CAD risk.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
486
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
691
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
235
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
201
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
107
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
141